Banner
Social Media Is A Faster Source For Unemployment Data Than Government

Government unemployment data today are what Nielsen TV ratings were decades ago - a flawed metric...

Gestational Diabetes Up 36% In The Last Decade - But Black Women Are Healthiest

Gestational diabetes, a form of glucose intolerance during pregnancy, occurs primarily in women...

Object-Based Processing: Numbers Confuse How We Perceive Spaces

Researchers recently studied the relationship between numerical information in our vision, and...

Males Are Genetically Wired To Beg Females For Food

Bees have the reputation of being incredibly organized and spending their days making sure our...

User picture.
News StaffRSS Feed of this column.

News Releases From All Over The World, Right To You... Read More »

Blogroll

The compound sulforaphane, whose natural precursors are found at high levels in broccoli and other cruciferous vegetables, has been hailed for its chemopreventive powers against cancer.

Now sulforaphane has demonstrated new skills in treating a genetic skin blistering disorder called epidermolysis bullosa simplex (EBS), Pierre Coulombe and colleagues at the Johns Hopkins University School of Medicine in Baltimore report at the American Society for Cell Biology 47th Annual Meeting.

EBS is a rare but devastating inherited condition in which fluid-filled lesions called bullae appear at sites of frictional trauma to the skin. Unfortunately, treatment options for EBS are limited and palliative in nature.

Finally, a win for human embryonic stem cells (hESCs).

Mice whose skulls were made whole again by bone tissue grown from hESCs shows that healing critical-size defects (defects that would not otherwise heal on their own) in intramembraneous bone, the flat bone type that forms the skull, is a vivid demonstration of new techniques to use hESCs for tissue regeneration.

Using mesenchymal precursor cells isolated from hESCs, the Hopkins team steered them into bone regeneration by using “scaffolds,” tiny, three-dimensional platforms made from biomaterials.

Researchers at Wageningen University, Netherlands, have shown that a drop in atmospheric nitrogen deposition will slow down forest growth. Lower tree growth implies less carbon sequestration and thus a decrease in the sequestration of carbon dioxide. This may have a significant impact on the targets set in the Kyoto protocol.

Researcher Wieger Wamelink of Wageningen University showed in model calculations that the carbon sequestration for all forests in The Netherlands, for example, may drop to 27 % of its present value. This reduced sequestration is expected as a result of pollution control policy strategies in all countries with present high nitrogen deposition, mainly located in Europe, North America and Asia.

Carbon dioxide is fixed in wood when a tree is growing.

Scientists at The University of Manchester have developed a new x-ray technique that could be used to detect hidden explosives, drugs and human cancers more effectively.

Professor Robert Cernik and colleagues from The School of Materials have built a prototype color 3D X-ray system that allows material at each point of an image to be clearly identified.

The technique developed by the Manchester scientists is known as tomographic energy dispersive diffraction imaging or TEDDI.

It harnesses all the wavelengths present in an x-ray beam to create probing 3D pictures.

A team led by the University of Colorado at Boulder and the University of Milan has discovered some unexpected forms of liquid crystals of ultrashort DNA molecules immersed in water, providing a new scenario for a key step in the emergence of life on Earth.

CU-Boulder physics Professor Noel Clark said the team found that surprisingly short segments of DNA, life's molecular carrier of genetic information, could assemble into several distinct liquid crystal phases that "self-orient" parallel to one another and stack into columns when placed in a water solution. Life is widely believed to have emerged as segments of DNA- or RNA-like molecules in a prebiotic "soup" solution of ancient organic molecules.

Direct-to-consumer advertising for commercial genetic testing is on the rise and may be problematic, according to a Massachusetts General Hospital physician. In the December issue of Obstetrics & Gynecology, Erin Tracy, MD, MPH, warns that such testing is poorly regulated and may present potential pitfalls for patients and physicians.

“Some of the tests that are being offered have no proven clinical validity whatsoever and are quite costly,” says Tracy. “So patients spend money trying to identify a particular gene to figure out if their child is prone to addictive behavior, for example.